Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Systematic reviews and meta-analyses suggest modest benefits for glycaemic control and lipid profiles in people with type 2 diabetes or metabolic syndrome, but the overall quality of evidence is considered moderate at best
Check for proper packaging, lot numbers, and expiration dates
Previously, GLP-1 medications which mimic the naturally occurring hormone glucagon-like peptide-1, which regulates blood sugar, digestion, and hunger had been approved only to treat obesity in the form of weekly, home-administered injections
Compared with older single pathway options, the goal is broader metabolic support that can translate into stronger and more consistent results for some patients
US$ 28.54
US$ 23.47
US$ 26.52
US$ 23.65
US$ 27.45
